Prognosticators of survival in patients with metastatic pancreatic cancer and ascites

JM Berger, A Alany, L Berchtold, R Puhr, A Friedrich, B Scheiner, GW Prager, M Preusser, AS Berghoff, ES Bergen · 2023

Read Prognosticators of survival in patients with metastatic pancreatic cancer and ascites by JM Berger, A Alany, L Berchtold, R Puhr, A Friedrich, B Scheiner, GW Prager, M Preusser, AS Berghoff, ES Bergen (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10774951.txt.

Description

Berger and co-authors published a 2023 study of survival after fluid buildup in the belly, called ascites, in patients with metastatic pancreatic cancer. Doctors at one Vienna center reviewed 117 such patients treated from 2010 to 2019. Survival after the ascites appeared was brutally short, a median of about 27 days. The team hunted for factors that mark better or worse odds.

Liver spread, spread across the abdominal lining, and a blocked portal vein each independently spelled shorter survival. Patients who continued systemic therapy after ascites lived a median of 62 days, against 16 days with supportive care alone. The authors say these markers can guide honest treatment talks. They caution that the therapy benefit needs testing in trials that also weigh quality of life.

Catalog record

CREATORJM Berger, A Alany, L Berchtold, R Puhr, A Friedrich, B Scheiner, GW Prager, M Preusser, AS Berghoff, ES Bergen
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10774951

Browse the full library · About the Tower of Babel